8-K: Sleep Number Reports Q3 2024 Results, Announces CEO Retirement

Sleep Number announced its third quarter 2024 results, reporting net sales of $427 million and adjusted EBITDA of $28 million, while also announcing the retirement of its CEO, Shelly Ibach.

Summary

• Sleep Number reported net sales of $427 million for the third quarter of 2024, a 10% decrease compared to the same period last year.
• The company's adjusted EBITDA for the quarter was $28 million, consistent with expectations.
• Gross margin improved significantly to 60.8%, up 340 basis points year-over-year, marking the highest quarterly rate since Q3 2021.
• Operating expenses were reduced by $17 million in the third quarter and $60 million year-to-date, before restructuring costs.
• Year-to-date free cash flow increased by $50 million compared to the same period last year.
• The company updated its full-year 2024 adjusted EBITDA outlook to a range of $115 million to $125 million.
• Full-year net sales are expected to be down approximately 10%, consistent with year-to-date performance.
• The company anticipates generating $10 million to $20 million of free cash flow for the year, with capital expenditures of approximately $25 million.
• CEO Shelly Ibach will retire no later than the 2025 Annual Meeting of Shareholders, and the board intends to appoint Michael J. Harrison as independent Chair.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to improved gross margins and cost reductions, but tempered by declining sales and a net loss. The CEO's retirement also introduces some uncertainty.

Positives

• The gross margin rate improved significantly to 60.8%, the highest since the third quarter of 2021.
• Operating expenses were reduced by $17 million for the quarter and $60 million year-to-date.
• Free cash flow increased by $50 million year-to-date compared to the same period last year.
• The company's leverage ratio of 4.2x EBITDAR is below the covenant maximum of 5.0x.
• The company is driving sustainable operating model improvements and increasing financial flexibility.

Negatives

• Net sales decreased by 10% compared to the prior year, totaling $427 million.
• The company experienced a net loss of $3.136 million for the quarter.
• Full-year net sales are expected to be down approximately 10%.
• The company is facing ongoing weakness in the bedding industry.

Risks

• The company is experiencing persistent consumer demand weakness.
• The bedding industry is facing ongoing challenges.
• The company's future financial results are subject to risks and uncertainties described in their SEC filings.
• The company's forward-looking statements are subject to certain risks and uncertainties which could cause the company's results to differ materially.

Future Outlook

The company expects full-year 2024 net sales to be down approximately 10% and adjusted EBITDA to be in the range of $115 million to $125 million. They also anticipate generating $10 million to $20 million of free cash flow for the year.

Management Comments

• Shelly Ibach stated that actions throughout the business are driving sustainable operating model improvements and contributing to increased financial flexibility.
• Shelly Ibach mentioned that the company continues to leverage its innovation superiority to provide customers with life-changing sleep solutions.
• Shelly Ibach expressed confidence in Sleep Number's continued market leadership and ability to accelerate profitable growth when industry demand recovers.

Industry Context

The company is operating in a challenging bedding industry environment, experiencing persistent consumer demand weakness. Despite this, Sleep Number is focusing on cost efficiencies and innovation to maintain its competitive position.

Comparison to Industry Standards

• While Sleep Number's gross margin improvement to 60.8% is a positive sign, it's important to compare this to competitors like Tempur Sealy International (TPX) and Purple Innovation (PRPL).
• TPX, for example, has historically maintained strong gross margins, and a comparison would show how Sleep Number's improvement stacks up against an industry leader.
• PRPL, known for its innovative mattress technology, also provides a benchmark for gross margin performance in the premium bedding segment.
• Sleep Number's 10% decline in net sales is a concern, and it would be useful to compare this to the sales performance of TPX and PRPL to understand if this is an industry-wide trend or specific to Sleep Number.
• The company's adjusted EBITDA of $28 million needs to be benchmarked against the EBITDA performance of its competitors to assess its profitability relative to the industry.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders may be concerned about the decrease in net sales and the net loss, but encouraged by the improved gross margin and cost reductions.
• Employees may experience uncertainty due to the CEO's retirement and potential organizational changes.
• Customers may benefit from the company's continued focus on innovation and improved sleep solutions.
• Suppliers may be impacted by the company's ongoing supplier negotiations and cost reduction efforts.
• Creditors may be reassured by the company's improved free cash flow and leverage ratio.

Next Steps

• The company will conduct a search for a new CEO.
• The board intends to appoint Michael J. Harrison as independent Chair at the 2025 Annual Meeting.
• The board intends to reduce its size with two longer-serving directors retiring at or before the 2026 Annual Meeting.
• The company will seek shareholder approval to declassify the board and adopt a majority voting standard at the 2025 Annual Meeting.

Key Dates

Keywords

Sleep Number, financial results, EBITDA, gross margin, net sales, free cash flow, CEO retirement, operating expenses, bedding industry, financial outlook